| Predicate | Object |
|---|---|
| rdf:type | |
| biopax3:comment |
FGFR1 gain-of-function mutations at P252 that result in increased binding affinity to ligand are presumed to be phosphorylated on the same sites as the wild-type receptor, although this has not been demonstrated (Ibrahimi, 2004a).<br><br>
|
| biopax3:xref | |
| biopax3:evidenceCode |